JYLAMVO

Formula & Concentration

JYLAMVO – methotrexate 2 mg/mL oral solution

Manufacturer

Shorla Oncology Inc.

Indications

Polyarticular juvenile idiopathic arthritis; rheumatoid arthritis; large granular lymphocytic leukemia; severe recalcitrant psoriasis; acute lymphoid leukemia; non-Hodgkin’s lymphoma; mycosis fungoides

Product Options

Package Size

NDC #

Presentation

2 mg/mL

81927-0204-01

Solution

Shelf Life and Storage

Controlled Room Temp (20-25°C)